Health
FDA approves HYMPAVZI for hemophilia patients
Marcus Rivera·
109 articles
Alembic Pharmaceuticals Limited secures USFDA final approval for Haloperidol Tablets across multiple strengths, expandin…
US health experts will screen wastewater for disease outbreaks during World Cup, a proactive measure to detect pathogens…
Pioneering Australian doctor Richard Scolyer dies at 59 after world-first experimental brain tumour treatment, leaving a…
A study reveals significant growing loneliness and healthcare gaps among the elderly in Upper Mustang, Nepal, driven by…
New daraxonrasib drug nearly doubles survival for advanced pancreatic cancer patients, marking a significant step in tre…
New treatment options for platinum-resistant ovarian cancer are emerging, offering hope and improved outcomes for patien…
Vertanical secures FDA breakthrough designation for a cannabis-based pain drug, signaling a major shift in pharmaceutica…
National Taxpayers Union asserts improved prescription drug safety can be achieved without financially burdening the pha…
Drugmakers continue COVID vaccine profits three years on, marking a significant financial achievement for pharmaceutical…
Neurology Live recently hosted a pivotal discussion on June 5, 2026, comparing stem cell therapy Parkinson’s treatments…
A new topical gel accelerates burn wound healing using an existing FDA-approved drug, promising faster recovery and impr…